Abstract
There are several types of primary tumors of the central nervous system (CNS), and almost half of them are gliomas. In particular, glioblastoma multiforme (GBM) is very aggressive and infiltrates into the CNS parenchyma. Despite intense clinical efforts, the prognosis of patients with this type of tumors remains very poor, and has not improved in decades, with a median survival of approximately one year after diagnosis. Current treatments include surgical resection, radiotherapy and chemotherapy. However, our knowledge regarding the genetic basis, as well as the molecular signaling pathways involved in the origin and progression of the tumors has increased significantly in the last few years, thus allowing the generation of new chemotherapeutic agents that are used together with sophisticated surgical and radiation techniques. Nevertheless, new approaches are necessary to develop effective treatments for these tumors. One of these novel strategies is gene therapy which is particularly well suited to treat gliomas. In this review we will discuss current therapeutic approaches, as well as critically analyzing gene therapy methods, the use of diverse viral and non-viral vectors, different genes and strategies to treat gliomas, from experimental models to clinical applications.
Current Medicinal Chemistry
Title: Conventional and Gene Therapy Strategies for the Treatment of Brain Tumors
Volume: 15 Issue: 8
Author(s): J. A. Benitez, G. Dominguez-Monzon and J. Segovia
Affiliation:
Abstract: There are several types of primary tumors of the central nervous system (CNS), and almost half of them are gliomas. In particular, glioblastoma multiforme (GBM) is very aggressive and infiltrates into the CNS parenchyma. Despite intense clinical efforts, the prognosis of patients with this type of tumors remains very poor, and has not improved in decades, with a median survival of approximately one year after diagnosis. Current treatments include surgical resection, radiotherapy and chemotherapy. However, our knowledge regarding the genetic basis, as well as the molecular signaling pathways involved in the origin and progression of the tumors has increased significantly in the last few years, thus allowing the generation of new chemotherapeutic agents that are used together with sophisticated surgical and radiation techniques. Nevertheless, new approaches are necessary to develop effective treatments for these tumors. One of these novel strategies is gene therapy which is particularly well suited to treat gliomas. In this review we will discuss current therapeutic approaches, as well as critically analyzing gene therapy methods, the use of diverse viral and non-viral vectors, different genes and strategies to treat gliomas, from experimental models to clinical applications.
Export Options
About this article
Cite this article as:
Benitez A. J., Dominguez-Monzon G. and Segovia J., Conventional and Gene Therapy Strategies for the Treatment of Brain Tumors, Current Medicinal Chemistry 2008; 15 (8) . https://dx.doi.org/10.2174/092986708783955491
DOI https://dx.doi.org/10.2174/092986708783955491 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances on Small-Molecule Survivin Inhibitors
Current Medicinal Chemistry The Tumor Suppressor Gene ARF as a Sensor of Oxidative Stress
Current Molecular Medicine A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties
Current Molecular Medicine A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab
Current Radiopharmaceuticals Heptahelical Receptors for Lysolipids in Lymphocytes as Targets for Therapeutic Intervention
Drug Design Reviews - Online (Discontinued) Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)
Current Pharmaceutical Design Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect
Current Pharmaceutical Biotechnology Exploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design Bioactive Metabolites from Pathogenic and Endophytic Fungi of Forest Trees
Current Medicinal Chemistry Importance of Aquaporins in the Physiopathology of Brain Edema
Current Pharmaceutical Design HDAC Inhibitors as Novel Anti-Cancer Therapeutics
Recent Patents on Anti-Cancer Drug Discovery NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews Recent Advances in Design of Potential Quinoxaline Anti-Infectives
Current Medicinal Chemistry Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets Nanoparticles Based on Plasma Proteins for Drug Delivery Applications
Current Pharmaceutical Design Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases
CNS & Neurological Disorders - Drug Targets Recent Advances in the Development of 14-Alkoxy Substituted Morphinans as Potent and Safer Opioid Analgesics
Current Medicinal Chemistry Estrogen Regulation of MicroRNA Expression
Current Genomics Effects of Diet-Derived Molecules on the Tumor Microenvironment
Current Angiogenesis (Discontinued)